DAX23.774 -3,5%Est505.783 -3,4%MSCI World4.343 -0,1%Top 10 Crypto8,6900 +2,2%Nas22.749 +0,4%Bitcoin57.442 -2,4%Euro1,1605 -0,7%Öl82,47 +5,6%Gold5.279 -0,8%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
freenet A0Z2ZZ AIXTRON A0WMPJ E.ON ENAG99 Münchener Rückversicherungs-Gesellschaft 843002 Heidelberg Materials 604700 Tesla A1CX3T Vonovia A1ML7J BioNTech (ADRs) A2PSR2 NEL ASA A0B733 AMD (Advanced Micro Devices) 863186 RWE 703712 Airbus 938914 Rolls-Royce A1H81L TKMS thyssenkrupp Marine Systems TKMS00 Micron Technology 869020
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nahostkonflikt: DAX unter 24.000 Punkten -- Asiens Börsen mit Verlusten -- Plug Power macht mehr Umsatz -- NVIDIA, AMD, Apple, Rüstungsaktien, DroneShield, SMA Solar, Vonovia, TUI, Nordex im Fokus
Top News
Nahostkrieg: USA und Israel geben Gründe für Krieg gegen den Iran Nahostkrieg: USA und Israel geben Gründe für Krieg gegen den Iran
NVIDIA setzt auf Photonik für die KI-Zukunft! NVIDIA setzt auf Photonik für die KI-Zukunft!
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

MediPharm Labs Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
0,0400 EUR -0,0028 EUR -6,54 %
STU
0,0700 CAD -0,0050 CAD -6,67 %
TSX
MediPharm Labs jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.19,82 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2N7AA

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINCA58504D1006

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolMEDIF

MediPharm Labs Aktien News

DatumMeistgelesen
PR NewswireCOMPLETE Board Change is Urgently Needed at MediPharm Labs! Apollo Technology Capital Corporation Files Amended and Restated Proxy Circular Detailing Prolonged Underperformance, Strategic Failures...
PR NewswireCOMPLETE Board Change is Urgently Needed at MediPharm Labs! Apollo Technology Capital Corporation Files Amended and Restated Proxy Circular Detailing Prolonged Underperformance, Strategic Failures...
PR NewswireApollo Capital Warns MediPharm Shareholders of Continued Value Destruction and Insolvency Risk Following Disastrous Q1 Financial Results
Wer­bungMediPharm Labs-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireApollo Capital Warns MediPharm Shareholders of Continued Value Destruction and Insolvency Risk Following Disastrous Q1 Financial Results
PR NewswireApollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders
PR NewswireApollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders
PR NewswireApollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction
PR NewswireApollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction
PR NewswireMediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana Health
PR NewswireMediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil
PR NewswireMediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5M
PR NewswireMediPharm Labs Reports Third Quarter Results
PR NewswireMediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results
PR NewswireMediPharm Labs Announces Departure of President and Co-Founder Keith Strachan
PR NewswireMediPharm Labs Announces Departure of President and Co-Founder Keith Strachan
PR NewswireMediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve
PR Newswire/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/
PR NewswireMediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results
PR NewswireMediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders
PR NewswireMediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols
PR NewswireMediPharm Labs Reports First Quarter Results
PR NewswireMediPharm Labs Sets Date to Report First Quarter 2024 Financial Results
PR NewswireMediPharm Labs Sets Date to Report First Quarter 2024 Financial Results
PR NewswireMediPharm Labs Provides Conference Call Recording Details
PR NewswireMediPharm Labs Reports Fourth Quarter and Full Year Results
PR NewswireMediPharm Labs Provides Update on German Cannabis Legalization
PR NewswireMediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results
PR NewswireMediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority
PR NewswireMediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program
PR NewswireMediPharm Labs Reports Third Quarter Results
PR NewswireMediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results
PR NewswireMediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash
PR NewswireMediPharm Labs Settles an Outstanding Claim for $9M
PR NewswireMediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market
PR NewswireMediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement
PR NewswireMediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million
PR NewswireMediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients
PR NewswireMediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth
PR NewswireMediPharm Labs Sets Date to Report Second Quarter 2023 Financial Results
PR NewswireMediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner and Provides Update on US FDA Status

MediPharm Labs News

MediPharm Labs News: auf dieser Seite finden Sie alle MediPharm Labs News und Nachrichten zur MediPharm Labs Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch MediPharm Labs News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um MediPharm Labs News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.